Ceragon (CRNT) Q1 2026 earnings review
Margin Expansion Masks a Demanding Growth Ramp
Ceragon's Q1 delivered a mixed reality: revenue contracted 4.1% YoY to $85.0 million, yet non-GAAP gross margins expanded impressively to 36.0%. The core narrative is a massive geographic mix shift—North America has surged to 37% of total sales, stabilizing the top line and offsetting India's decline from a year ago. While management reiterated aggressive FY26 guidance ($355-$385M), achieving it requires a steep revenue acceleration in the remaining quarters. Combined with explicit CEO warnings about rising macro costs and FX pressures, the margin expansion story faces imminent tests.
🐂 Bull Case
Non-GAAP gross margin hit 36.0%, up from 33.5% a year ago. The shift toward higher-margin North American revenues is structurally improving Ceragon's profitability baseline despite lower overall volumes.
The region now accounts for 37% of total revenue. Activity with a new Tier 1 CSP is progressing well, with potential for initial orders to start converting as early as Q3.
🐻 Bear Case
To hit the $370M FY26 guidance midpoint, Ceragon must average $95M per quarter for the rest of the year—a massive acceleration from Q1's $85M run rate.
Management explicitly warned that industry-wide cost increases and adverse foreign currency trends could pressure margins in the near term.
⚖️ Verdict: ⚪
Neutral. The margin execution is highly commendable and North America is acting as a sturdy anchor. However, the top line is still contracting YoY, and the math required to hit FY26 guidance leaves no room for error in the back half of the year.
Key Themes
North America Reclaims Top Spot
The geographic mix shift is accelerating. North America represented 37% of Q1 2026 revenue, up dramatically from 20% in Q1 2025. This shift toward a traditionally higher-margin region is the primary driver behind the non-GAAP gross margin expanding to 36.0%. Progression with a new Tier 1 CSP adds visibility to H2.
FR2 and E-Band Innovation Fueling Pipeline
Technological innovation remains a core growth driver. E-band solutions are successfully driving demand across multiple regions. Furthermore, the company completed a successful Proof of Concept (POC) with a major North American carrier for its new FR2 solution, sparking increased interest across both North American and European markets.
Private Networks Diversification
Ceragon continues to expand its Private Networks business. Management noted diverse contract wins across various customers and use cases in Q1, proving that the strategic pivot away from pure telecom carrier dependence is slowly gaining traction.
Contradiction: Guidance Demands Steep Acceleration
While management cited 'positive momentum,' the math tells a riskier story. Q1 revenue was $85.0M. To achieve the reiterated FY26 guidance midpoint of $370M, the company must generate $285M over the next three quarters—averaging $95M per quarter. This requires growth to shift from Reversing/Decelerating to aggressively Accelerating, carrying significant execution risk.
Macro and FX Pressures Threaten Margin Stability
Despite a strong Q1 margin beat, the CEO explicitly warned that 'recent macro and industry-wide cost increases and continued adverse foreign currency trends may lead to higher pressure on our margins, especially in the near term.' This macro vulnerability must be closely monitored.
APAC Segment Collapse
APAC is severely lagging the company average. In Q1 2025, APAC represented 10% of total revenue (~$8.9M). In Q1 2026, it fell to just 6% of a smaller revenue base (~$5.1M), representing an approximate 42% YoY collapse in the region. This is a Decelerating trend that requires management explanation.
Other KPIs
The balance sheet is stable. Cash and cash equivalents grew sequentially to $39.2 million from $38.4 million at the end of 2025. The company noted positive free cash flow, indicating that working capital is being managed effectively despite the slight revenue contraction.
The gap between GAAP and non-GAAP results remains noticeable. Operating expenses heavily impacted GAAP results, resulting in a ($0.01) EPS loss, while non-GAAP EPS eked out a $0.01 profit. Investors should watch the adjustments (likely stock-based comp and amortization) bridging this gap.
Guidance
Reiterated. This implies an Accelerating trajectory vs Q1, as the $370M midpoint implies roughly 9% YoY growth over FY25's ~$338.7M, whereas Q1 started the year down 4.1% YoY.
Reiterated. Stable to Accelerating. Given Q1's strong 36.0% print, the company is already tracking well against this goal, provided the North American mix holds and macro cost mitigation is effective.
Reiterated. At the $370M revenue midpoint, this implies ~$26M in annual non-GAAP operating income. Q1 delivered $4.2M, meaning operating leverage must kick in hard during H2 to hit this target.
Key Questions
Bridging the Revenue Gap
With Q1 revenue at $85M, the implied run-rate for the rest of the year is $95M per quarter to hit the guidance midpoint. Exactly which regions and product lines are providing the confidence for this steep acceleration?
Margin Defense Strategy
You explicitly flagged macro cost increases and FX trends as near-term margin pressures. What specific pricing actions or supply chain adjustments are currently being implemented to protect the 36% gross margin profile?
APAC Weakness
Revenues in the APAC region dropped to 6% of total mix, implying a severe YoY contraction. Is this a timing issue with specific project deployments, or a structural loss of market share?
Tier 1 Order Timing
You noted potential initial orders from a new North American Tier 1 CSP starting in Q3. Is this timeline firmly contracted, and how material are these initial orders to achieving your Q3/Q4 revenue targets?